Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001813640 | SCV002060732 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869613 | SCV002293084 | uncertain significance | RASopathy | 2022-07-20 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 119 of the CBL protein (p.Met119Val). ClinVar contains an entry for this variant (Variation ID: 1334225). This variant has not been reported in the literature in individuals affected with CBL-related conditions. This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CBL protein function. |